# Biocon Biologics Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d

> Inspection records and compliance data for Biocon Biologics Limited in Bengaluru, None. Access full analysis and detailed observations.

---

## Details

- Name: Biocon Biologics Limited
- FEI Number: 3003981475
- City: Bengaluru
- State: None
- Country Name: India
- Address Line 1: Block No, B1,B2, B3, B5, Q13 Of Q1 And W20 & Unit S18,1st Floor, Block B4, Sez, Plot No.2,3,4&5, Phase Iv, Bommasandra-Jigani Link Road
- Zip Code: None
- Facility Type: Drug Substance & Drug Product Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK

## Related Documents

- [483 - Biocon Biologics Limited - Unknown Date](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/1dff6c9a-dd43-4ecd-bfcd-53b9e68b1d05) — source: FDA, date: Invalid Date
- [483 - Biocon Biologics Limited - Unknown Date](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/fdee272a-ef56-45fc-8061-233169edfabf) — source: FDA, date: Invalid Date
- [483 - Biocon Biologics Limited - Unknown Date](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/34a3f80d-5688-4e63-9006-3751d02f3b25) — source: FDA, date: Invalid Date
- [483 - Biocon Biologics Limited - 2024-07-26](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/05a654d1-f83f-49b1-80a9-56f70dca615f) — source: FDA, date: July 26, 2024
- [FDA Inspection 1245708 - Biocon Biologics Limited - 2024-07-26](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/687d3404-f2a1-4dc0-bfbb-745764ac52d8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2024
- [483 - Biocon Biologics Limited - 2022-08-26](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/389806fd-0ee4-4841-b19c-fe0c775d7c7b) — source: FDA, date: August 26, 2022
- [483 - Biocon Biologics Limited - 2022-08-26](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/6d696c01-1fee-4b41-9f1e-ae5c564a08fa) — source: FDA, date: August 26, 2022
- [483 - Biocon Biologics Limited - 2022-08-19](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/152eb2db-adeb-44c2-883a-bdac69a6cc99) — source: FDA, date: August 19, 2022
- [483 - Biocon Biologics Limited - 2019-09-19](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/81b17a36-3d2a-4a82-a70c-77f6fce4507a) — source: FDA, date: September 19, 2019
- [FDA Inspection 1100840 - Biocon Biologics Limited - 2019-08-30](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/bda77216-5fdd-4704-b7c9-90ceecdde4ef) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2019
- [483 - Biocon Biologics Limited - 2019-02-15](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/3858f9b9-9837-4adb-9001-eeb4c7a62761) — source: FDA, date: February 15, 2019
- [483 - Biocon Biologics Limited - 2018-05-01](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/6fa7e974-b5c4-450b-bb8f-8eb76ae4b514) — source: FDA, date: May 1, 2018
- [FDA Inspection 1050980 - Biocon Biologics Limited - 2018-05-01](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/7991b681-ff48-4be4-b758-595d97e70837) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 1, 2018
- [FDA Inspection 1016114 - Biocon Biologics Limited - 2017-06-03](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/7328e444-a60d-4390-b252-256bf9a29dfd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 3, 2017
- [FDA Inspection 948968 - Biocon Biologics Limited - 2015-10-29](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/92298ebd-8a54-4a80-b128-b2fb9600f04a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2015
- [FDA Inspection 934266 - Biocon Biologics Limited - 2015-06-16](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/c1f2aae7-0bfb-472b-8e5c-6db5f4b991e8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2015
- [FDA Inspection 793259 - Biocon Biologics Limited - 2012-06-19](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/9ed98396-a244-4332-8c0f-c1b60197af63) — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012
- [FDA Inspection 790624 - Biocon Biologics Limited - 2012-06-13](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/c0aaaa2f-b9dd-40db-a287-715ce2ae717f) — classification: No Action Indicated (NAI), source: FDA, date: June 13, 2012
- [FDA Inspection 560965 - Biocon Biologics Limited - 2009-01-29](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/fa65562b-baef-4889-bd71-fad0982c1dcc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2009
- [FDA Inspection 584568 - Biocon Biologics Limited - 2009-01-29](https://www.globalkeysolutions.net/records/fda_inspections/biocon-biologics-limited/9fb37f43-dc0d-4a0c-9005-4f96d55a7f82) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2009

## Related Companies

- [Eugia Pharma Specialities Limited](https://www.globalkeysolutions.net/companies/eugia-pharma-specialities-limited/9733456f-3189-4fe6-a4f9-327f0ce92559)
- [Dr Reddy's Laboratories Limited](https://www.globalkeysolutions.net/companies/dr-reddys-laboratories-limited/97f3d461-62f0-4198-9e9d-7f7c7d43af86)
- [Mankind Pharma Limited](https://www.globalkeysolutions.net/companies/mankind-pharma-limited/448ddf49-4ff4-4a2b-8444-e8cc23677777)
- [EUGIA Pharma Specialities Limited](https://www.globalkeysolutions.net/companies/eugia-pharma-specialities-limited/7c9f680c-5d29-42a0-a496-02fd4761792b)
- [Pharmathen International S.A.](https://www.globalkeysolutions.net/companies/pharmathen-international-sa/4486b3e5-4ce8-40ff-80da-e4364db37198)
- [Evonik Corporation](https://www.globalkeysolutions.net/companies/evonik-corporation/f88f3afa-3508-4fc2-8d70-8558ece37d59)
- [Strides Pharma Science Limited](https://www.globalkeysolutions.net/companies/strides-pharma-science-limited/8cbbf469-967b-461a-9ab3-357517269fe2)
- [Catalent Maryland, Inc.](https://www.globalkeysolutions.net/companies/catalent-maryland-inc/b2f722ce-b6bd-42e6-b648-cec5c4b5f44d)
- [Kelix bio (Malta) Ltd.](https://www.globalkeysolutions.net/companies/kelix-bio-malta-ltd/3595e81b-9a31-4dcc-b529-e58034aabdf7)
- [PharmaGend Global Medical Services Pte. Ltd.](https://www.globalkeysolutions.net/companies/pharmagend-global-medical-services-pte-ltd/a4dcdf70-101c-46bc-94ab-ddb8956f44a4)

## Related Officers

- [Scott Nichols, Ph.D., Microbiologist](https://www.globalkeysolutions.net/people/scott-nichols-phd-microbiologist/2b5696a8-21cc-4b58-8c90-9950f4c43849)
- [Richard Ledwidge, Ph.D., Biologist](https://www.globalkeysolutions.net/people/richard-ledwidge-phd-biologist/51161c1e-63da-4f24-bf8b-ecc1398c9dbe)
- [Diane Raccasi](https://www.globalkeysolutions.net/people/diane-raccasi/5c51bbf4-9c91-49c5-a1a5-d5aa7374890b)
- [Investigator](https://www.globalkeysolutions.net/people/michael-r-shanks/dd24952b-4309-451e-afe8-f68892cd7bac)
- [investigator](https://www.globalkeysolutions.net/people/laura-fontan/b27b02a3-9ab1-49df-b2bc-ee936b69d76a)
- [Laurie A. Nelson](https://www.globalkeysolutions.net/people/laurie-a-nelson/dbd373d1-ce1f-486c-a932-d93f8f52832d)